📌 Lupin Sentiment: 🟢 Positive 📑 Lupin has received tentative approval from the U.S. FDA for its Oxcarbazepine Extended-Release (ER) Tablets. The product will be manufactured at the company’s Nagpur facility. 💰 Market Potential: The estimated annual U.S. sales for the product stand at $206 million.